Demonstrating Bioequivalence of Locally Acting Orally Inhaled Drug Products (OIPs): Workshop Summary Report

Journal of Aerosol Medicine and Pulmonary Drug Delivery
Wallace P AdamsLawrence X Yu

Abstract

This March 2009 Workshop Summary Report was sponsored by Product Quality Research Institute (PQRI) based on a proposal by the Inhalation and Nasal Technology Focus Group (INTFG) of the American Association of Pharmaceutical Scientists (AAPS). Participants from the pharmaceutical industry, academia and regulatory bodies from the United States, Europe, India, and Brazil attended the workshop with the objective of presenting, reviewing, and discussing recommendations for demonstrating bioequivalence (BE) that may be considered in the development of orally inhaled drug products and regulatory guidances for new drug applications (NDAs), abbreviated NDAs (ANDAs), and postapproval changes. The workshop addressed areas related to in vitro approaches to demonstrating BE, biomarker strategies, imaging techniques, in vivo approaches to establishing local delivery equivalence and device design similarity. The workshop presented material that provided a baseline for the current understanding of orally inhaled drug products (OIPs) and identified gaps in knowledge and consensus that, if answered, might allow the design of a robust, streamlined method for the BE assessment of locally acting inhalation drugs. These included the following: (1) c...Continue Reading

References

May 1, 1977·Clinical Allergy·D W CockcroftF E Hargreave
Apr 1, 1992·The Journal of Allergy and Clinical Immunology·E Y DeromM E Van der Straeten
Mar 1, 1990·Archives of Disease in Childhood·S PedersenG Fuglsang
Oct 1, 1994·The European Respiratory Journal·L ThorssonT B Conradson
Jan 15, 1994·Lancet·S A KharitonovP J Barnes
Jun 17, 1998·The American Journal of Medicine·B LipworthD Hendrick
Sep 29, 1998·The Journal of Asthma : Official Journal of the Association for the Care of Asthma·P E SilkoffN Zamel
Jan 7, 1999·The European Respiratory Journal·L Thorsson, S Edsbäcker
Jan 20, 1999·Respiratory Medicine·N RingdalR Pauwels
Mar 5, 1999·The European Respiratory Journal·J A BennettA E Tattersfield
May 5, 1999·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·P GeoffroyJ Grossman
Jul 3, 1999·American Journal of Respiratory and Critical Care Medicine·K N ParameswaranF E Hargreave
Oct 6, 1999·American Journal of Respiratory and Critical Care Medicine·R C AhrensS H Han
Mar 10, 2001·Clinical Pharmacology and Therapeutics·UNKNOWN Biomarkers Definitions Working Group.
Oct 24, 2001·American Journal of Respiratory and Critical Care Medicine·R C AhrensC R Lux
Nov 6, 2001·Journal of Aerosol Medicine : the Official Journal of the International Society for Aerosols in Medicine·T C LinD L Swift
Jul 11, 2002·The European Respiratory Journal·J Beck-RippP Bufler
Jul 5, 2003·Advanced Drug Delivery Reviews·Stephen P NewmanLisa Rankin
Jul 10, 2003·British Journal of Clinical Pharmacology·Graeme P CurrieBrian J Lipworth
Oct 24, 2003·Journal of Aerosol Medicine : the Official Journal of the International Society for Aerosols in Medicine·M MolimardN Moore
Mar 5, 2004·Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology·Petr PohunekTamara Svobodová
May 4, 2004·Journal of Aerosol Medicine : the Official Journal of the International Society for Aerosols in Medicine·W TarsinH Chrystyn
Nov 13, 2004·The Journal of Allergy and Clinical Immunology·Philip E SilkoffStanley J Szefler
Apr 9, 2005·American Journal of Respiratory and Critical Care Medicine·UNKNOWN American Thoracic Society, UNKNOWN European Respiratory Society
Jun 30, 2005·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·Brian J LipworthMichelle Paterson
Dec 16, 2005·The AAPS Journal·Lloyd D Fricker
Dec 29, 2005·Journal of Aerosol Medicine : the Official Journal of the International Society for Aerosols in Medicine·Håkan Bagger-JörgensenMikael Sundahl
May 6, 2006·The Journal of Allergy and Clinical Immunology·Margaret M KellyFrederick E Hargreave

❮ Previous
Next ❯

Citations

Apr 2, 2011·Journal of Aerosol Medicine and Pulmonary Drug Delivery·Martyn F BiddiscombeOmar S Usmani
Apr 2, 2011·Journal of Aerosol Medicine and Pulmonary Drug Delivery·Dennis O'ConnorSandra Suarez Sharp
Mar 15, 2012·Journal of Aerosol Medicine and Pulmonary Drug Delivery·Carole EvansPatricia Watson
Dec 19, 2012·Journal of Aerosol Medicine and Pulmonary Drug Delivery·Timothy E CorcoranPhilip J Kuehl
Feb 28, 2013·Therapeutic Delivery·Gabriela Apiou-SbirleaAnthony Hickey
Mar 15, 2014·American Journal of Respiratory and Critical Care Medicine·Charles S HaworthDiana Bilton
Dec 8, 2010·Journal of Aerosol Medicine and Pulmonary Drug Delivery·Gerhard ScheuchSteve Newman
Dec 8, 2011·Inhalation Toxicology·Philip J KuehlJacob D McDonald
Nov 15, 2013·Expert Opinion on Drug Delivery·Federico LavoriniRichard Pn Dekhuijzen
Dec 24, 2014·Expert Opinion on Drug Delivery·Andrew R Martin, Warren H Finlay
Jun 28, 2011·Expert Opinion on Drug Delivery·Peter T Daley-Yates, David A Parkins
Feb 6, 2013·Journal of Pharmaceutical Sciences·Anthony J Hickey
Feb 2, 2016·Journal of Aerosol Medicine and Pulmonary Drug Delivery·Chantal DarquenneOtmar Schmid
Apr 28, 2016·Clinical Pharmacology in Drug Development·Ashish SharmaBernd Meibohm
Nov 13, 2012·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·S StegemannA Hincal
Aug 2, 2011·International Journal of Pharmaceutics·Wenlei JiangLawrence X Yu
Dec 15, 2010·Advanced Drug Delivery Reviews·Ben ForbesRon K Wolff
Feb 7, 2016·Drug Development and Industrial Pharmacy·Bo JiangHuahao Shen
Jun 28, 2011·Pharmaceutical Development and Technology·Barbara D AlexanderAnthony J Hickey
Mar 13, 2015·The AAPS Journal·Günther HochhausJuliet Rebello
Jan 16, 2015·The AAPS Journal·Stefan LeinerOrest Lastow
Mar 26, 2013·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·D A LewisD Traini
Mar 27, 2013·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·M HaghiP M Young
Jan 11, 2012·Molecular Pharmaceutics·C I GraingerB Forbes
Nov 14, 2016·Journal of Pharmaceutical Sciences·Joanna MuddleBen Forbes
May 5, 2017·Therapeutic Delivery·John N Pritchard
Jul 15, 2017·Journal of Aerosol Medicine and Pulmonary Drug Delivery·Irvin Mayers, Mohit Bhutani
Jul 22, 2017·Therapeutic Delivery·Stephen P Newman
Aug 4, 2012·Journal of Aerosol Medicine and Pulmonary Drug Delivery·Pamela McCormackPaul S McNamara
May 11, 2019·Pharmaceutical Research·Masahiro SakagamiJügen Venitz
Sep 23, 2010·Expert Opinion on Drug Delivery·John Denyer
Sep 30, 2010·European Journal of Pediatrics·Jan Mazela, Richard A Polin

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.